Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity
Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that is based on innovation and scientific rigor and integrity. Our goal is to create novel products to meet critical patient needs, including novel imaging-based diagnostic tools to improve the detection of occurrence, progression, and regression of neurological diseases, and novel therapies to improve the treatment of human neurological conditions.